[Odinophagia and cutaneous lesions in patient with cerebral metastases].
García Sánchez
I
I
Servicio de Medicina Interna, Hospital General Universitario Gregorio Marañón, Madrid.
Chavarria Mur
E
E
Avilés Izquierdo
J
J
Molina Sánchez-Cabezudo
F
F
Vera López
E
E
Gilsanz Fernández
C
C
D000368:Aged; D000927:Anticonvulsants / Q000009:adverse effects*; D001415:Back; D001932:Brain Neoplasms / Q000150:complications* / Q000556:secondary*; D016572:Cyclosporine / Q000627:therapeutic use; D020405:Dermis / Q000473:pathology; D004827:Epilepsy / Q000175:diagnosis / Q000209:etiology; D017809:Fatal Outcome; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D009061:Mouth Mucosa / Q000187:drug effects* / Q000473:pathology*; D009336:Necrosis / Q000139:chemically induced / Q000473:pathology; D010672:Phenytoin / Q000009:adverse effects*; D012871:Skin Diseases / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology*; D013262:Stevens-Johnson Syndrome / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology*
D000927:Anticonvulsants; D007166:Immunosuppressive Agents; D010672:Phenytoin; D016572:Cyclosporine